{"entity":{"type":"insider","cik":"0001899977","url":"/insider/0001899977","json_url":"/insider/0001899977.json","name":"Schneyer Mark C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":27,"first":"2022-02-25","last":"2026-08-07","span_basis":"filed_date"},"name_variants":[{"name":"Schneyer Mark C.","source":"filing","n_filings":27,"first_seen":"2022-02-25","last_seen":"2026-08-07"}],"transactions":[{"id":5889442,"accession":"0001899977-26-000008","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001899977-26-000008","line_url":"/filing/0001899977-26-000008","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14292.0,"shares_display":"14,292","price_per_share":29.21942695214106,"price_display":"29.22","price_state":"stated","total_value":417604.05,"total_display":"417,604.05","total_whole":"417,604","shares_owned_after":67828.0,"shares_owned_after_display":"67,828","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-06","filed_date":"2026-08-07","scope":"insider","n_lines":2},{"id":5889436,"accession":"0001899977-26-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001899977-26-000008","line_url":"/filing/0001899977-26-000008#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5849.0,"shares_display":"5,849","price_per_share":29.0029,"price_display":"29.00","price_state":"stated","total_value":169637.9621,"total_display":"169,637.96","total_whole":"169,638","shares_owned_after":67828.0,"shares_owned_after_display":"67,828","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-05","filed_date":"2026-08-07","scope":"insider"},{"id":5912510,"accession":"0001899977-26-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001899977-26-000007","line_url":"/filing/0001899977-26-000007#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3506.0,"shares_display":"3,506","price_per_share":21.79,"price_display":"21.79","price_state":"stated","total_value":76395.74,"total_display":"76,395.74","total_whole":"76,396","shares_owned_after":66145.0,"shares_owned_after_display":"66,145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-04","filed_date":"2026-05-05","scope":"insider"},{"id":6231436,"accession":"0001899977-26-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001899977-26-000005","line_url":"/filing/0001899977-26-000005#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2709.0,"shares_display":"2,709","price_per_share":22.2,"price_display":"22.20","price_state":"stated","total_value":60139.8,"total_display":"60,139.80","total_whole":"60,140","shares_owned_after":62836.0,"shares_owned_after_display":"62,836","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-07","filed_date":"2026-04-07","scope":"insider"},{"id":5877270,"accession":"0001899977-26-000003","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001899977-26-000003","line_url":"/filing/0001899977-26-000003","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3208.0,"shares_display":"3,208","price_per_share":21.650777369077307,"price_display":"21.65","price_state":"stated","total_value":69455.6938,"total_display":"69,455.69","total_whole":"69,456","shares_owned_after":60306.0,"shares_owned_after_display":"60,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-26","filed_date":"2026-03-26","scope":"insider","n_lines":2},{"id":5877266,"accession":"0001899977-26-000003","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001899977-26-000003","line_url":"/filing/0001899977-26-000003#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4177.0,"shares_display":"4,177","price_per_share":21.47,"price_display":"21.47","price_state":"stated","total_value":89680.19,"total_display":"89,680.19","total_whole":"89,680","shares_owned_after":57299.0,"shares_owned_after_display":"57,299","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-25","filed_date":"2026-03-26","scope":"insider"},{"id":4606978,"accession":"0001899977-25-000006","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001899977-25-000006","line_url":"/filing/0001899977-25-000006#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10262.0,"shares_display":"10,262","price_per_share":23.6907,"price_display":"23.69","price_state":"stated","total_value":243113.9634,"total_display":"243,113.96","total_whole":"243,114","shares_owned_after":53338.0,"shares_owned_after_display":"53,338","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-18","filed_date":"2025-11-19","scope":"insider"},{"id":5101092,"accession":"0001899977-25-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001899977-25-000004","line_url":"/filing/0001899977-25-000004#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3498.0,"shares_display":"3,498","price_per_share":23.65,"price_display":"23.65","price_state":"stated","total_value":82727.7,"total_display":"82,727.70","total_whole":"82,728","shares_owned_after":43447.0,"shares_owned_after_display":"43,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-15","filed_date":"2025-09-16","scope":"insider"},{"id":4886641,"accession":"0001415889-25-022359","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-022359","line_url":"/filing/0001415889-25-022359#line-1","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22000.0,"shares_display":"22,000","price_per_share":25.1829,"price_display":"25.18","price_state":"stated","total_value":554023.8,"total_display":"554,023.80","total_whole":"554,024","shares_owned_after":40130.0,"shares_owned_after_display":"40,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-19","scope":"insider"},{"id":4175869,"accession":"0001415889-25-013741","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-013741","line_url":"/filing/0001415889-25-013741#line-1","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","total_whole":"50,000","shares_owned_after":62130.0,"shares_owned_after_display":"62,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-19","scope":"insider"},{"id":4211296,"accession":"0001415889-25-011872","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-011872","line_url":"/filing/0001415889-25-011872#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3498.0,"shares_display":"3,498","price_per_share":14.6,"price_display":"14.60","price_state":"stated","total_value":51070.8,"total_display":"51,070.80","total_whole":"51,071","shares_owned_after":62773.0,"shares_owned_after_display":"62,773","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-02","filed_date":"2025-05-02","scope":"insider"},{"id":4245326,"accession":"0001415889-25-010424","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-010424","line_url":"/filing/0001415889-25-010424#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2708.0,"shares_display":"2,708","price_per_share":14.82,"price_display":"14.82","price_state":"stated","total_value":40132.56,"total_display":"40,132.56","total_whole":"40,133","shares_owned_after":59456.0,"shares_owned_after_display":"59,456","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-08","filed_date":"2025-04-08","scope":"insider"},{"id":4589349,"accession":"0001415889-25-009074","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-009074","line_url":"/filing/0001415889-25-009074#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3171.0,"shares_display":"3,171","price_per_share":17.05,"price_display":"17.05","price_state":"stated","total_value":54065.55,"total_display":"54,065.55","total_whole":"54,066","shares_owned_after":56889.0,"shares_owned_after_display":"56,889","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-26","filed_date":"2025-03-26","scope":"insider"},{"id":4050654,"accession":"0001415889-25-005574","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-005574","line_url":"/filing/0001415889-25-005574#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":773.0,"shares_display":"773","price_per_share":19.96,"price_display":"19.96","price_state":"stated","total_value":15429.08,"total_display":"15,429.08","total_whole":"15,429","shares_owned_after":53882.0,"shares_owned_after_display":"53,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-24","filed_date":"2025-02-25","scope":"insider"},{"id":2191093,"accession":"0001415889-24-027292","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-027292","line_url":"/filing/0001415889-24-027292#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10259.0,"shares_display":"10,259","price_per_share":16.81,"price_display":"16.81","price_state":"stated","total_value":172453.79,"total_display":"172,453.79","total_whole":"172,454","shares_owned_after":53302.0,"shares_owned_after_display":"53,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-19","filed_date":"2024-11-19","scope":"insider"},{"id":2190552,"accession":"0001415889-24-021731","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-021731","line_url":"/filing/0001415889-24-021731#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9733.0,"shares_display":"9,733","price_per_share":15.28,"price_display":"15.28","price_state":"stated","total_value":148720.24,"total_display":"148,720.24","total_whole":"148,720","shares_owned_after":43735.0,"shares_owned_after_display":"43,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-19","filed_date":"2024-08-20","scope":"insider"},{"id":2485338,"accession":"0001415889-24-016416","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-016416","line_url":"/filing/0001415889-24-016416#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":975.0,"shares_display":"975","price_per_share":14.79,"price_display":"14.79","price_state":"stated","total_value":14420.25,"total_display":"14,420.25","total_whole":"14,420","shares_owned_after":34564.0,"shares_owned_after_display":"34,564","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-10","filed_date":"2024-06-11","scope":"insider"},{"id":2660819,"accession":"0001415889-24-012237","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-012237","line_url":"/filing/0001415889-24-012237#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3503.0,"shares_display":"3,503","price_per_share":16.94,"price_display":"16.94","price_state":"stated","total_value":59340.82,"total_display":"59,340.82","total_whole":"59,341","shares_owned_after":32053.0,"shares_owned_after_display":"32,053","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-02","filed_date":"2024-05-03","scope":"insider"},{"id":2189479,"accession":"0001415889-24-010601","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-010601","line_url":"/filing/0001415889-24-010601#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2716.0,"shares_display":"2,716","price_per_share":17.87,"price_display":"17.87","price_state":"stated","total_value":48534.92,"total_display":"48,534.92","total_whole":"48,535","shares_owned_after":28742.0,"shares_owned_after_display":"28,742","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-08","filed_date":"2024-04-09","scope":"insider"},{"id":2952912,"accession":"0001415889-24-009270","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-009270","line_url":"/filing/0001415889-24-009270#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5434.0,"shares_display":"5,434","price_per_share":17.9,"price_display":"17.90","price_state":"stated","total_value":97268.6,"total_display":"97,268.60","total_whole":"97,269","shares_owned_after":26183.0,"shares_owned_after_display":"26,183","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-27","filed_date":"2024-03-27","scope":"insider"},{"id":2100554,"accession":"0001415889-24-005577","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-005577","line_url":"/filing/0001415889-24-005577#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":772.0,"shares_display":"772","price_per_share":24.67,"price_display":"24.67","price_state":"stated","total_value":19045.24,"total_display":"19,045.24","total_whole":"19,045","shares_owned_after":21067.0,"shares_owned_after_display":"21,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-26","filed_date":"2024-02-27","scope":"insider"},{"id":8753950,"accession":"0001209191-23-056357","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-056357","line_url":"/filing/0001209191-23-056357#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5108.0,"shares_display":"5,108","price_per_share":22.64,"price_display":"22.64","price_state":"stated","total_value":115645.12,"total_display":"115,645.12","total_whole":"115,645","shares_owned_after":20486.0,"shares_owned_after_display":"20,486","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-20","filed_date":"2023-11-21","scope":"insider"},{"id":7899100,"accession":"0001209191-23-047125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-047125","line_url":"/filing/0001209191-23-047125#line-1","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":28.997,"price_display":"29.00","price_state":"stated","total_value":289970.0,"total_display":"289,970.00","total_whole":"289,970","shares_owned_after":15682.0,"shares_owned_after_display":"15,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-21","filed_date":"2023-08-23","scope":"insider"},{"id":8372231,"accession":"0001209191-23-036529","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-036529","line_url":"/filing/0001209191-23-036529#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":974.0,"shares_display":"974","price_per_share":25.02,"price_display":"25.02","price_state":"stated","total_value":24369.48,"total_display":"24,369.48","total_whole":"24,369","shares_owned_after":22824.0,"shares_owned_after_display":"22,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-08","filed_date":"2023-06-12","scope":"insider"},{"id":7972139,"accession":"0001209191-23-031243","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-031243","line_url":"/filing/0001209191-23-031243#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15310.0,"shares_display":"15,310","price_per_share":22.5,"price_display":"22.50","price_state":"stated","total_value":344475.0,"total_display":"344,475.00","total_whole":"344,475","shares_owned_after":21905.0,"shares_owned_after_display":"21,905","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-17","filed_date":"2023-05-19","scope":"insider"},{"id":8072182,"accession":"0001209191-23-023863","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-023863","line_url":"/filing/0001209191-23-023863#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1916.0,"shares_display":"1,916","price_per_share":18.16,"price_display":"18.16","price_state":"stated","total_value":34794.56,"total_display":"34,794.56","total_whole":"34,795","shares_owned_after":7477.0,"shares_owned_after_display":"7,477","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-06","filed_date":"2023-04-07","scope":"insider"},{"id":8606145,"accession":"0001209191-23-013470","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-013470","line_url":"/filing/0001209191-23-013470#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":577.0,"shares_display":"577","price_per_share":18.78,"price_display":"18.78","price_state":"stated","total_value":10836.06,"total_display":"10,836.06","total_whole":"10,836","shares_owned_after":4118.0,"shares_owned_after_display":"4,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-24","filed_date":"2023-02-27","scope":"insider"},{"id":6304770,"accession":"0001209191-22-036176","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-036176","line_url":"/filing/0001209191-22-036176#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":653.0,"shares_display":"653","price_per_share":17.9095,"price_display":"17.91","price_state":"stated","total_value":11694.9035,"total_display":"11,694.90","total_whole":"11,695","shares_owned_after":3342.0,"shares_owned_after_display":"3,342","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-09","filed_date":"2022-06-10","scope":"insider"},{"id":6693599,"accession":"0001209191-22-013281","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-013281","line_url":"/filing/0001209191-22-013281#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001899977","owner_name":"Schneyer Mark C.","owner_display_name":"Schneyer Mark C.","owner_url":"/insider/0001899977","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":553.0,"shares_display":"553","price_per_share":23.8,"price_display":"23.80","price_state":"stated","total_value":13161.4,"total_display":"13,161.40","total_whole":"13,161","shares_owned_after":2102.0,"shares_owned_after_display":"2,102","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-23","filed_date":"2022-02-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":31,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":31,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":31},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001070494","name":"ACADIA PHARMACEUTICALS INC","url":"/issuer/0001070494","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","n_filings":27,"first_seen":"2022-02-25","last_seen":"2026-08-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001899977","retrieved_at":"2026-08-27T03:05:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}